- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.5M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.16M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.27M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$16.29M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.96M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.12M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$37.31M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$36.19M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $20.69M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $21.92M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $45.88M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $50.02M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.09M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.01M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.57M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $13.83M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$4.22 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$13.16 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$4.22 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$13.16 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.73M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.26M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.58M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $12.36M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.34M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$15.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$9.31M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$17.61M |